We also compared iR expression and function in CD8 T cells from tumor-infiltrated lymph nodes (TILN) in melanoma patients with similar results, in agreement with previous studies where we showed that PD1+ CD8 T cells from PBMC from melanoma patients are not necessarily impaired (80). This evidence concerns the gene INSR and melanoma.